BioHarvest Sciences (BHST) Competitors $11.80 +0.80 (+7.27%) As of 09/24/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BHST vs. RGNX, NBTX, CYRX, ETON, REPL, ERAS, PRTA, ALMS, CRVS, and ITOSShould you be buying BioHarvest Sciences stock or one of its competitors? The main competitors of BioHarvest Sciences include REGENXBIO (RGNX), Nanobiotix (NBTX), CryoPort (CYRX), Eton Pharmaceuticals (ETON), Replimune Group (REPL), Erasca (ERAS), Prothena (PRTA), Alumis (ALMS), Corvus Pharmaceuticals (CRVS), and iTeos Therapeutics (ITOS). These companies are all part of the "pharmaceutical products" industry. BioHarvest Sciences vs. Its Competitors REGENXBIO Nanobiotix CryoPort Eton Pharmaceuticals Replimune Group Erasca Prothena Alumis Corvus Pharmaceuticals iTeos Therapeutics REGENXBIO (NASDAQ:RGNX) and BioHarvest Sciences (NASDAQ:BHST) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings. Do institutionals and insiders hold more shares of RGNX or BHST? 88.1% of REGENXBIO shares are held by institutional investors. 12.8% of REGENXBIO shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has better earnings & valuation, RGNX or BHST? BioHarvest Sciences has lower revenue, but higher earnings than REGENXBIO. BioHarvest Sciences is trading at a lower price-to-earnings ratio than REGENXBIO, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioREGENXBIO$83.33M5.78-$227.10M-$3.44-2.77BioHarvest Sciences$25.19M7.69-$12.91M-$0.70-16.86 Do analysts prefer RGNX or BHST? REGENXBIO presently has a consensus target price of $28.38, suggesting a potential upside of 197.43%. BioHarvest Sciences has a consensus target price of $13.67, suggesting a potential upside of 15.82%. Given REGENXBIO's higher possible upside, research analysts plainly believe REGENXBIO is more favorable than BioHarvest Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score REGENXBIO 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83BioHarvest Sciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is RGNX or BHST more profitable? BioHarvest Sciences has a net margin of -39.95% compared to REGENXBIO's net margin of -112.70%. REGENXBIO's return on equity of -66.95% beat BioHarvest Sciences' return on equity.Company Net Margins Return on Equity Return on Assets REGENXBIO-112.70% -66.95% -34.14% BioHarvest Sciences -39.95%-11,357.84%-39.94% Which has more volatility & risk, RGNX or BHST? REGENXBIO has a beta of 1.17, meaning that its stock price is 17% more volatile than the S&P 500. Comparatively, BioHarvest Sciences has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Does the media refer more to RGNX or BHST? In the previous week, BioHarvest Sciences had 1 more articles in the media than REGENXBIO. MarketBeat recorded 3 mentions for BioHarvest Sciences and 2 mentions for REGENXBIO. REGENXBIO's average media sentiment score of 0.82 beat BioHarvest Sciences' score of 0.57 indicating that REGENXBIO is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment REGENXBIO 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioHarvest Sciences 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryREGENXBIO beats BioHarvest Sciences on 10 of the 16 factors compared between the two stocks. Get BioHarvest Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for BHST and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BHST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHST vs. The Competition Export to ExcelMetricBioHarvest SciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$180.68M$3.14B$5.78B$10.41BDividend YieldN/A2.36%5.68%4.62%P/E Ratio-16.8620.7676.1526.42Price / Sales7.69403.60527.63170.46Price / CashN/A45.9137.5661.52Price / Book147.509.8312.926.39Net Income-$12.91M-$52.73M$3.29B$271.13M7 Day Performance35.63%1.84%0.79%0.93%1 Month Performance42.17%7.48%4.95%7.52%1 Year PerformanceN/A19.92%68.38%30.06% BioHarvest Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHSTBioHarvest Sciences1.7606 of 5 stars$11.80+7.3%$13.67+15.8%N/A$180.68M$25.19M-16.86N/AHigh Trading VolumeRGNXREGENXBIO4.6017 of 5 stars$9.20-3.1%$28.38+208.4%-14.9%$479.38M$83.33M-2.67370NBTXNanobiotix0.9151 of 5 stars$9.70-2.5%$8.00-17.5%+241.8%$477.03M$39.18M0.00100Upcoming EarningsCYRXCryoPort3.7385 of 5 stars$8.64-8.8%$12.00+38.9%+20.3%$474.13M$228.38M6.501,186Positive NewsHigh Trading VolumeETONEton Pharmaceuticals2.0617 of 5 stars$17.65+0.5%$29.67+68.1%+246.6%$471.19M$58.18M-110.3120Positive NewsREPLReplimune Group4.518 of 5 stars$5.73-4.7%$6.50+13.4%-62.4%$469.12MN/A-1.77210ERASErasca2.5004 of 5 stars$1.56-3.1%$3.71+138.1%-24.7%$456.71MN/A-3.47120PRTAProthena2.9489 of 5 stars$8.21-2.6%$19.75+140.6%-57.7%$453.79M$135.16M-1.46130ALMSAlumis2.8826 of 5 stars$4.37+0.2%$20.17+361.5%-63.8%$453.72MN/A0.00N/ACRVSCorvus Pharmaceuticals1.6303 of 5 stars$5.83-3.8%$15.00+157.3%+25.1%$451.55MN/A-5.7730ITOSiTeos Therapeutics2.7846 of 5 stars$10.15flat$15.50+52.7%N/A$448.73M$35M-2.1790Positive News Related Companies and Tools Related Companies REGENXBIO Competitors Nanobiotix Competitors CryoPort Competitors Eton Pharmaceuticals Competitors Replimune Group Competitors Erasca Competitors Prothena Competitors Alumis Competitors Corvus Pharmaceuticals Competitors iTeos Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BHST) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioHarvest Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioHarvest Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
